The Coca-Cola Co K vs 22nd Century Group Inc — how do they compare? The Coca-Cola Co K trades at $82.05 (market cap $353.32B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: The Coca-Cola Co K is far larger — about 237127.5× 22nd Century Group Inc's market cap, and The Coca-Cola Co K pays a 2.58% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| KO | XXII | |
|---|---|---|
Market Cap | $353.32B | $1.49M |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Technology |
52-Week High | $84.92 | $1.07K |
52-Week Low | $65.67 | $3.90 |
Enterprise Value | $383.39B | -$6.74M |
Dividend Yield | 2.58% | — |
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $82.08, up 0.64% on the day, with a bullish analyst consensus and strong earnings beats in recent quarters. The stock shows robust profitability with a 27.8% net margin and 45.8% ROE, though valuations like a P/E of 25.82 are elevated. Technicals are mixed with a bearish overall signal but support near $82. Recent news highlights institutional buying and stable demand trends ahead of Q2 earnings.
Outlook remains positive given consistent dividend growth, earnings outperformance, and a $90.67 price target. Risks include high debt levels and regional demand volatility. The stock offers stability for income investors but faces valuation pressures amid macroeconomic uncertainty.
XXII trades at $4.32, down 0.23% with bearish technical signals. The company shows negative profitability with -65.76% net income margin and -130.19% ROE, though valuation ratios appear low with P/S of 0.03. Recent corporate actions include a 20:1 reverse stock split in June 2026. The company is expanding VLN product distribution in key markets including California and New York, supported by positive FDA regulatory developments.
While analyst consensus is 75% buy-rated, fundamental challenges persist with consistent revenue declines and negative cash flow from operations. Investment opportunity lies in successful VLN brand expansion and regulatory approvals, but risks include ongoing losses, competitive tobacco market pressures, and execution uncertainty in scaling reduced-nicotine products.
Trailing returns across standard periods
Latest headlines on both assets
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →